Pharmaron Nominates New Board Director Candidates

Stock News04-28 20:10

Pharmaron (03759) announced that, in accordance with the company's director nomination policy, (i) Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei have been nominated by shareholders as candidates for executive director; (ii) Ms. Wan Xuan has been nominated by shareholders as a candidate for non-executive director; and (iii) Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong have been nominated as independent non-executive director candidates, recommended by the board's nomination committee and nominated by the board. According to the company's articles of association, the term for the third board of directors is three years. Following the completion of this term, Mr. Li Jiaqing and Mr. Yu Jian will not participate in the election for the fourth board of directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1130875399?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130875399","market":"us","top_or_hot":-1,"title":"Pharmaron Nominates New Board Director Candidates","media":"Stock News","content":"<p>Pharmaron (03759) announced that, in accordance with the company's director nomination policy, (i) Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei have been nominated by shareholders as candidates for executive director; (ii) Ms. Wan Xuan has been nominated by shareholders as a candidate for non-executive director; and (iii) Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong have been nominated as independent non-executive director candidates, recommended by the board's nomination committee and nominated by the board. According to the company's articles of association, the term for the third board of directors is three years. Following the completion of this term, Mr. Li Jiaqing and Mr. Yu Jian will not participate in the election for the fourth board of directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Nominates New Board Director Candidates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Nominates New Board Director Candidates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-04-28 20:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron (03759) announced that, in accordance with the company's director nomination policy, (i) Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei have been nominated by shareholders as candidates for executive director; (ii) Ms. Wan Xuan has been nominated by shareholders as a candidate for non-executive director; and (iii) Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong have been nominated as independent non-executive director candidates, recommended by the board's nomination committee and nominated by the board. According to the company's articles of association, the term for the third board of directors is three years. Following the completion of this term, Mr. Li Jiaqing and Mr. Yu Jian will not participate in the election for the fourth board of directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1130875399","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130875399","pubTimestamp":1777378218,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Pharmaron (03759) announced that, in accordance with the company's director nomination policy, (i) Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei have been nominated by shareholders as...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","03759":"康龙化成","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","BK0216":"研究试验"},"translate_title":"康龙化成提名新董事会董事候选人","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"03759":1},"content_text":"Pharmaron (03759) announced that, in accordance with the company's director nomination policy, (i) Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei have been nominated by shareholders as candidates for executive director; (ii) Ms. Wan Xuan has been nominated by shareholders as a candidate for non-executive director; and (iii) Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong have been nominated as independent non-executive director candidates, recommended by the board's nomination committee and nominated by the board. According to the company's articles of association, the term for the third board of directors is three years. Following the completion of this term, Mr. Li Jiaqing and Mr. Yu Jian will not participate in the election for the fourth board of directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1130875399","isCrawlerRequest":true}